Shenzhen JYMed Technology Co., Ltd (JY-Med), established in 2009, is an innovative pharmaceutical company engaged in research and development, manufacturing and commercialization of peptides based products with independent intellectual property rights. JY-Med has two wholly-owned subsidiaries, Shenzhen JX Bio-pharmaceutical Co., Ltd and Hubei JX Bio-pharmaceutical Co., Ltd. JYMed takes a lead in domestic in developing products of natural products with defined targets and extended release formulation for peptide and protein drugs. Mastering advanced technologies, JY-Med is capable of manufacturing cutting-edge peptide drugs for the world market. Since got the investment from XinYing Pharmaceutical Group in 2010, JY-Med has marched into a fast-growing period with its registered capital added from RMB 2 million to RMB 89.5 million.
JYMed has established long-term cooperation with several colleges, universities and institutions both at home and abroad. JYMed owned a first-class consulting team expert in project management, R&D and marketing. In the park of Shenzhen High-tech Bio-incubator, the company has a research center over 2000㎡equipped with a well-established system and instruments such as HPLC, preparative chromatograph, MS, GC, ion chromatograph, as well as pilot scale production line for extended release microsphere. Meanwhile, in Pingshan district, Shenzhen, a facility of 5000㎡ in compliance with requirements of national technology centers has been built for developing new products.
Till now, JYMed has established two manufacturing bases and a new one is scheduled to be built in Xianan, Hubei. The base in Nanjing is built with 4 peptide API production lines in compliance with FDA requirements. Part of products has been exporting to Europe, America and other major drug markets. The base in Pingshan, Shenzhen consists of two production lines in compliance with GMP guidelines which mainly produce formulation such as cassette bottle injections, small volume injections and Lyophilized powder for injection. In Hubei, Xian’an Economic Development Zone, the company has purchased about 300 acres land scheduled to build a new production base in compliance with US FDA, EU and Chinese GMP standards for the production of new peptide drugs.
In recent years, JYMed has been honored as one of the New High-tech Enterprises of Shenzhen and New High-tech Enterprises of the State. By virtue of informatization management, JY-Med has developed a strict quality control system and comprehensive management measures to ensure sustainable development of the company. As always, JYers will make every effort to seek for breakthroughs in technology and management innovation on the basis of flexible and reasonable marketing strategies and support of its excellent leaders and staff. Adhering to the core values of “integrity, responsibility, efficiency and partnership”, JYMed is committed to be an innovative and trustworthy enterprise who persevere to provide reliable pharmaceutical products for human health!
